Biocon receives Health Canada approval for Bosaya and Vevzuo biosimilars to Prolia and Xgeva
Denosumab biosimilars approved in Canada to expand access for osteoporosis and cancer-related bone conditions
Denosumab biosimilars approved in Canada to expand access for osteoporosis and cancer-related bone conditions
Veteran pharma leader brings 33+ years of experience to drive operational excellence in formulation business
Growth was broad-based across segments
Angelique Kruif brings over 20 years of HR leadership built across a range of international organisations
Sanplatec is leading the industry in the field of containers and devices for cell culture and live transport
The system is powered by BrainSense technology, which has received approval from USFDA
New regional hub strengthens presence in a key market and enhances service delivery for corporate healthcare clients
The newly approved pill combines 100 mg of doravirine with 0.25 mg of islatravir
Targets high-growth eye care expansion push
Manoj has over two decades of experience in healthcare operations and biomedical engineering
Subscribe To Our Newsletter & Stay Updated